FDA advisory panel on the safety and efficacy of drug-eluting stents: summary of findings and recommendations.
Tufts Medical School, Boston, MA 21140, USA. Jeffrey.Popma@caritaschristi.org
Jeffrey J
JJ
Popma
Bonnie
B
Weiner
Michael J
MJ
Cowley
Charles
C
Simonton
Dan
D
McCormick
Ted
T
Feldman
D000818:Animals; D054855:Drug-Eluting Stents / Q000009:adverse effects; D004730:Endothelium, Vascular / Q000503:physiopathology; D006801:Humans; D015999:Multivariate Analysis; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011474:Prosthesis Design; D016032:Randomized Controlled Trials as Topic; D012042:Registries; D013927:Thrombosis / Q000503:physiopathology; D014481:United States; D014486:United States Food and Drug Administration
D010975:Platelet Aggregation Inhibitors